How CRISPR and AI Destroy the World Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste.

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

In the rapidly evolving field of genetic engineering, few names resonate as profoundly as George Church, a geneticist at Harvard University. Known for his groundbreaking work in genomics, Church has ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...